|
CI25-10137
|
Design and Fabrication of Drug-Eluting Biodegradable Polycaprolactone mesh implants
|
Maria Elisabete Teixeira da Silva
|
Institute of Science and Innovation in Mechanical and Industrial Engineering (INEGI)
|
Consortium
|
Universidade do Porto
|
STAGE 1
|
Medical Devices
|
49.924,56
|
|
CI25-10210
|
Fully Automatic Occluding Device Sizing for LAAC in 3D TEE
|
Pedro Morais
|
2Ai - Applied Artificial Intelligence Laboratory Instituto Politécnico do Cávado e do Ave
|
Individual
|
N/A
|
STAGE 1
|
Digital Health
|
50.000,00
|
|
CI25-10249
|
Next-Generation Antimicrobials: A Precision Medicine Approach to Gram-Negative Infections
|
Marc Torrent
|
Universitat Autònoma de Barcelona (UAB)
|
Individual
|
N/A
|
STAGE 1
|
Therapeutics
|
49.000,00
|
|
CI25-10265
|
Advanced Gamma Detectors for Precision Medicine and Theranostics
|
Pedro Correia
|
University of Aveiro
i3N - Institute of Nanostructures, Nanomodeling and Nanofabrication
|
Individual
|
N/A
|
STAGE 1
|
Medical Devices
|
50.000,00
|
|
CI25-10269
|
Boosting spine REGENeration with customized fetal matrIX ingredients
|
Joana Caldeira
|
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação
|
Individual
|
N/A
|
STAGE 1
|
Therapeutics
|
50.000,00
|
|
CI25-10325
|
Engineered Biocomputers for Real-Time Tumor Monitoring
|
Marta R. Casanova
|
Universidade do Minho
|
Individual
|
N/A
|
STAGE 1
|
Diagnostics
|
49.939,60
|
|
CI25-10354
|
Blood-brain barrier-on-a-chip (BBB-oC) for drug testing of brain-targeting delivery
|
Anna Lagunas
|
Fundació Institut de Bioenginyeria de Catalunya
|
Individual
|
N/A
|
STAGE 1
|
Diagnostics
|
50.000,00
|
|
CI25-10370
|
MicroAspiration Retrieval System - A novel thrombectomy device for distal vessel occlusion strokes
|
Marc Ribó
|
Fundació Hospital Universitari Vall d´Hebron - Institut de Recerca (VHIR)
|
Individual
|
N/A
|
STAGE 1
|
Medical Devices
|
49.000,00
|
|
CI25-10420
|
Monitoring Chamber based on Cherenkov for FLASH beam monitoring and control
|
Pedro Assis
|
Laboratório de Instrumentação e Física Experimental de Partículas
|
Individual
|
N/A
|
STAGE 1
|
Medical Devices
|
50.000,00
|
|
CI25-10446
|
Preclinical development of a first-in-class treatment for autism spectrum disorder
|
Mercè Pallàs
|
Universitat de Barcelona
|
Consortium
|
Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P.
|
STAGE 1
|
Therapeutics
|
50.000,00
|
|
CI25-10447
|
CUstom-MAde DEvice design for Complex Structural Heart Diseases
|
Dabit Arzamendi
|
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
|
Individual
|
N/A
|
STAGE 1
|
Medical Devices
|
50.000,00
|
|
CI25-10473
|
AI-Powered Screening of R-loop Modulators for Cancer Therapy
|
Robert Martin
|
Fundação GIMM - Gulbenkian Institute for Molecular Medicine
|
Individual
|
N/A
|
STAGE 1
|
Therapeutics
|
50.000,00
|
|
CI25-10539
|
Harness lncRNA targeting to enhance treatment for colorectal cancer
|
Luisa Statello
|
Fundación para la Investigación Médica Aplicada (FIMA/CIMA)
|
Individual
|
N/A
|
STAGE 1
|
Therapeutics
|
50.000,00
|
|
CI25-10647
|
A Nanovaccine-Based Immunotherapy Targeting Klebsiella pneumoniae Colonization
|
Astrid Pérez
|
Instituto de Salud Carlos III
|
Individual
|
N/A
|
STAGE 1
|
Therapeutics
|
49.000,00
|
|
CI25-10655
|
Generating Artificial Targets to Deliver Therapies Selectively to the Brain
|
Daniel González
|
Fundació Institut de Bioenginyeria de Catalunya
|
Individual
|
N/A
|
STAGE 1
|
Therapeutics
|
50.000,00
|
|
CI25-10683
|
Combining the power of surgery and light in the treatment of cancer
|
Ana Piqueras Hinojo
|
Fundació Institut d’Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)
|
Individual
|
N/A
|
STAGE 1
|
Medical Devices
|
50.000,00
|
|
CI25-10749
|
LINE-1 Identification for novel elements with active retrotransposition
|
Marc Güell
|
Universitat Pompeu Fabra (UPF)
|
Individual
|
N/A
|
STAGE 1
|
Therapeutics
|
49.000,00
|
|
CI25-20009
|
An innovative biopolymer for ophthalmologic treatments
|
Anna Roig
|
Institut de Ciència de Materials de Barcelona (ICMAB)
Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC)
|
Individual
|
N/A
|
STAGE 2
|
Medical Devices
|
150.000,00
|
|
CI25-20024
|
Automating Preoperative Assessments for Enhanced Patient Care and Healthcare Efficiency
|
Ancor Serrano
|
Institut d´Investigació Biomèdica de Bellvitge (IDIBELL)
|
Individual
|
N/A
|
STAGE 2
|
Medical Devices
|
149.482,89
|
|
CI25-20156
|
A TDP-43 sensor for the diagnosis of neurodegenerative diseases
|
María del Valle Palomo
|
Fundación IMDEA Nanociencia
|
Consortium
|
Fundación para la Investigación Biomédica del Hospital Clínico San Carlos
|
STAGE 2
|
Diagnostics
|
150.000,00
|
|
CI25-20197
|
Validation of a novel epigenetic decoding of blood DNA to predict clinical benefit of immunotherapy
|
Isabel Barragán
|
Fundación para la Investigación de Málaga en Biomedicina y Salud
|
Individual
|
N/A
|
STAGE 2
|
Diagnostics
|
145.200,00
|
|
CI25-20385
|
Non-Invasive Prediction of the Benefit of Immunotherapy in Advanced Lung Cancer
|
Mónica Martínez-Fernández
|
Instituto de Investigación Sanitaria Galicia Sur (IISGS)
|
Individual
|
N/A
|
STAGE 2
|
Medical Devices
|
150.000,00
|
|
CI25-20397
|
TAR-NK: A TGF-β- and Activin A-Resistant off-the-shelf NK cell product for cancer treatment
|
Aura Muntasell
|
Hospital del Mar Research Institute (HMRIB)
|
Individual
|
N/A
|
STAGE 2
|
Therapeutics
|
144.100,00
|
|
CI25-20532
|
4D bioresorbable stent: a lifelong solution for pediatric aortic coarctation
|
Andrés García
|
IQS School Of Engineering, Universitat Ramon Llull
|
Consortium
|
Universitat Politècnica de Catalunya (UPC)
|
STAGE 2
|
Medical Devices
|
148.500,00
|
|
CI25-20596
|
Engineering a technology for site-specific transgene delivery in tumors using tumor-specific T cells
|
Alba Rodriguez
|
Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer
|
Individual
|
N/A |
STAGE 2
|
Therapeutics
|
149.952,00
|
|
CI25-20598
|
Allowing adoptive T cell therapies in solid tumors
|
Joan Seoane
|
Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)
|
Individual
|
N/A
|
STAGE 2
|
Therapeutics
|
150.000,00
|
|
CI25-20711
|
Accelerating an armored CAR T cell therapy for metastatic/refractory bone and soft tissue sarcoma
|
Clara Bueno
|
Institut de Recerca Contra la Leucèmia Josep Carreras
|
Consortium
|
Fundació Privada per a la Recerca i la Docència Sant Joan de Déu
|
STAGE 2
|
Therapeutics
|
149.600,00
|
|
CI25-2U079
|
Overcoming resistance to virotherapy for pediatric brain tumors
|
Marta M Alonso
|
Fundación para la Investigación Médica Aplicada (Cima Universidad de Navarra)
|
Individual
|
N/A
|
STAGE 2
|
Therapeutics
|
150.000,00
|
|
CI25-30194
|
ACE: Advance Cutaneous Evaluator
|
Óscar Pérez
|
Fundación Centro Tecnolóxico de Telecomunicacións de Galicia (GRADIANT)
|
Consortium
|
Fundación Pública Galega de Investigación Biomédica Galicia Sur
|
STAGE 3
|
Medical Devices
|
500.000,00
|
|
CI25-30479
|
TREX2 inhibitors: a breakthrough keratinocyte-based therapy for Psoriasis and beyond
|
Sara Preciado
|
Institut d´Investigació Biomèdica de Bellvitge (IDIBELL)
|
Individual
|
N/A
|
STAGE 3
|
Therapeutics
|
499.999,50
|
|
CI25-3U559
|
DUFIC, a device for in vivo uterine fluid collection
|
Pilar Coy
|
Universidad de Murcia
|
Individual
|
N/A
|
STAGE 3
|
Medical Devices
|
500.000,00
|
